News

Error in Part B template for DIGITAL-EMERGING-02 calls

Published on | 1 year ago

Programmes Digital, Industry & Space

If you are preparing a proposal for either

  • HORIZON-CL4-2024-DIGITAL-EMERGING-02-01 - Developing and deploying a network of quantum gravimeters in Europe
  • HORIZON-CL4-2024-DIGITAL-EMERGING-02-02 - Stimulating transnational research and development of next generation quantum technologies, including basic theories and components

then please make sure that you use the correct version of the Part B template, now available in the submission system, before proceeding with the drafting of your proposal. Because there was a mix-up in the original publication of the documents 4 weeks ago.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1744 articles available search in articles 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.